HK1217199A1 - 促進幹細胞分化為肝細胞的化合物 - Google Patents
促進幹細胞分化為肝細胞的化合物Info
- Publication number
- HK1217199A1 HK1217199A1 HK16105247.2A HK16105247A HK1217199A1 HK 1217199 A1 HK1217199 A1 HK 1217199A1 HK 16105247 A HK16105247 A HK 16105247A HK 1217199 A1 HK1217199 A1 HK 1217199A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hepatocytes
- compounds
- stem cell
- cell differentiation
- improved stem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361792019P | 2013-03-15 | 2013-03-15 | |
US201361811155P | 2013-05-22 | 2013-05-22 | |
PCT/EP2014/054763 WO2014140058A1 (en) | 2013-03-15 | 2014-03-12 | Compounds for improved stem cell differentiation into hepatocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1217199A1 true HK1217199A1 (zh) | 2016-12-30 |
Family
ID=50272618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16105247.2A HK1217199A1 (zh) | 2013-03-15 | 2016-05-09 | 促進幹細胞分化為肝細胞的化合物 |
Country Status (11)
Country | Link |
---|---|
US (2) | US9334480B2 (zh) |
EP (1) | EP2970178B1 (zh) |
JP (1) | JP6129360B2 (zh) |
KR (1) | KR101767802B1 (zh) |
CN (1) | CN105051023B (zh) |
BR (1) | BR112015023185A2 (zh) |
CA (1) | CA2900690A1 (zh) |
HK (1) | HK1217199A1 (zh) |
MX (1) | MX346497B (zh) |
RU (1) | RU2662954C2 (zh) |
WO (1) | WO2014140058A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3720441A1 (en) | 2017-12-04 | 2020-10-14 | H. Hoffnabb-La Roche Ag | Pyrrolo[2,3-b]pyrazine compounds as cccdna inhibitors for the treatment of hepatitis b virus (hbv) infection |
AU2021235252A1 (en) | 2020-03-11 | 2022-10-06 | Bit Bio Limited | Method of generating hepatic cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
EP1669441A1 (en) * | 2003-08-27 | 2006-06-14 | Renomedix Institute Inc. | Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell |
WO2007136300A2 (fr) * | 2006-05-23 | 2007-11-29 | Alla Chem, Llc | Indoles substitués et procédé de production et d'utilisation de ceux-ci |
JP6008297B2 (ja) * | 2011-04-15 | 2016-10-19 | 国立大学法人鳥取大学 | ヒト間葉系幹細胞を肝細胞へ分化誘導する新規化合物の合成と解析 |
-
2014
- 2014-03-12 BR BR112015023185A patent/BR112015023185A2/pt not_active IP Right Cessation
- 2014-03-12 WO PCT/EP2014/054763 patent/WO2014140058A1/en active Application Filing
- 2014-03-12 CN CN201480012330.0A patent/CN105051023B/zh not_active Expired - Fee Related
- 2014-03-12 MX MX2015011505A patent/MX346497B/es active IP Right Grant
- 2014-03-12 KR KR1020157025369A patent/KR101767802B1/ko active IP Right Grant
- 2014-03-12 CA CA2900690A patent/CA2900690A1/en not_active Abandoned
- 2014-03-12 JP JP2015562101A patent/JP6129360B2/ja not_active Expired - Fee Related
- 2014-03-12 RU RU2015140469A patent/RU2662954C2/ru not_active IP Right Cessation
- 2014-03-12 EP EP14709646.5A patent/EP2970178B1/en not_active Not-in-force
- 2014-03-12 US US14/205,893 patent/US9334480B2/en active Active
-
2015
- 2015-02-03 US US14/612,893 patent/US9181218B2/en not_active Expired - Fee Related
-
2016
- 2016-05-09 HK HK16105247.2A patent/HK1217199A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2970178A1 (en) | 2016-01-20 |
WO2014140058A1 (en) | 2014-09-18 |
JP6129360B2 (ja) | 2017-05-17 |
CN105051023A (zh) | 2015-11-11 |
JP2016511276A (ja) | 2016-04-14 |
KR20150119342A (ko) | 2015-10-23 |
KR101767802B1 (ko) | 2017-08-11 |
MX346497B (es) | 2017-03-22 |
US20150197726A1 (en) | 2015-07-16 |
EP2970178B1 (en) | 2017-06-14 |
RU2662954C2 (ru) | 2018-07-31 |
MX2015011505A (es) | 2016-01-22 |
US20150158840A1 (en) | 2015-06-11 |
US9181218B2 (en) | 2015-11-10 |
CN105051023B (zh) | 2017-08-22 |
BR112015023185A2 (pt) | 2017-07-18 |
CA2900690A1 (en) | 2014-09-18 |
US9334480B2 (en) | 2016-05-10 |
RU2015140469A (ru) | 2017-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL246262A0 (en) | Cell culture media | |
HK1223553A1 (zh) | 細胞 | |
IL241627B (en) | A method for t-cell activation | |
EP2997133C0 (en) | METHODS FOR PRODUCING, BY GENETIC ENGINEERING, A HIGHLY ACTIVE T-CELL FOR IMMUNOTHERAPEUTIC USE | |
HK1216761A1 (zh) | 用於神經細胞培養的培養基組合物 | |
PL2758523T3 (pl) | Zrębowe komórki macierzyste | |
GB201318126D0 (en) | Neuronal Stem Cell Differentiation | |
HK1221250A1 (zh) | 用於培養細胞的結構件 | |
IL245392A0 (en) | A method for cell culture | |
HK1222886A1 (zh) | 哺乳動物肌源性幹細胞 | |
GB201420277D0 (en) | Cell culture system | |
SG11201509767UA (en) | Medium for culturing stem cells | |
GB201310031D0 (en) | Cell | |
EP2978839A4 (en) | CELL CULTURE METHOD | |
GB201303101D0 (en) | Media for stem cells | |
HK1217199A1 (zh) | 促進幹細胞分化為肝細胞的化合物 | |
SG11201507338PA (en) | Method for culturing cells | |
GB201310354D0 (en) | Method for cell differentiation | |
GB201308905D0 (en) | Cell culture | |
GB201306488D0 (en) | Cell culture | |
GB201320573D0 (en) | T Cell | |
GB201317589D0 (en) | Cell | |
GB201307708D0 (en) | Method for cell enrichment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230310 |